Ambit Biosciences (San Diego, CA), a clinical-stage biotechnology company focused on kinase-based therapeutics for cancer, closed a $25M Series E financing. Participants include OrbiMed Advisors, Aisling Capital, Apposite Healthcare, Roche Ventures, GrowthWorks, MedImmune Ventures, Forward Ventures, GIMV, and Radius Ventures.

Collective IP | The World’s Largest Technology Transfer Office Marketplace

Providing Unrivaled Comprehensive and Accurate Access to Humankinds Most Valuable and Transformative Assets

Receive Collective IP Account Access HERE